Profile data is unavailable for this security.
About the company
AdaptHealth Corp. is a provider of patient-centric and technology-enabled chronic disease management solutions. The Company provides home healthcare equipment, medical supplies to the home and related services in the United States. It is focused primarily on providing sleep therapy equipment, supplies and related services to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes, home medical equipment (HME) to patients discharged from acute care and other facilities. The Company also offers oxygen and related chronic therapy services in the home, and other HME medical devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. The Company services beneficiaries of Medicare, Medicaid, and commercial payors.
- Revenue in USD (TTM)2.12bn
- Net income in USD-42.36m
- Incorporated2017
- Employees8.70k
- LocationAdapthealth Corp220 W Germantown Pike Ste 250PLYMOUTH MEETING 19462United StatesUSA
- Phone+1 (610) 630-6357
- Fax+1 (302) 636-5454
- Websitehttps://adapthealth.com/investor-relations/
More ▼
Mergers & acquisitions
| Acquired company | AHCO:NAQ since announced | Transaction value |
|---|---|---|
| Home Medical Products & Services Inc | -11.27% | -- |
| Upstate HomeCare | -34.80% | -- |
| Healthy Living Medical Supply LLC | -31.77% | -- |
Data delayed at least 15 minutes, as of Jan 27 2022 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Outset Medical Inc | 91.70m | -122.75m | 1.64bn | 313.00 | -- | 3.99 | -- | 17.86 | -2.77 | -2.77 | 2.06 | 8.71 | 0.2005 | 3.77 | 6.95 | 292,961.70 | -26.83 | -- | -29.21 | -- | 5.13 | -- | -133.86 | -- | 9.64 | -90.75 | 0.0677 | -- | 231.18 | -- | 7.18 | -- | -- | -- |
| Lantheus Holdings Inc | 389.80m | -34.48m | 1.64bn | 595.00 | -- | 3.29 | 410.27 | 4.22 | -0.5112 | -0.5112 | 5.78 | 7.38 | 0.4513 | 6.12 | 6.88 | 655,122.70 | -3.99 | 6.05 | -4.40 | 6.96 | 43.80 | 47.97 | -8.84 | 7.43 | 2.18 | -4.08 | 0.2618 | 0.00 | -2.28 | 2.95 | -142.55 | -- | -1.05 | -- |
| Cytek Biosciences Inc | -100.00bn | -100.00bn | 1.80bn | 462.00 | -- | 4.47 | -- | -- | -- | -- | -- | 3.01 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 13.74 | -- | 0.00 | -- | 60.39 | -- | 119.11 | -- | -- | -- |
| Fulgent Genetics Inc | 1.04bn | 569.33m | 1.80bn | 429.00 | 3.14 | 1.74 | 3.15 | 1.74 | 19.24 | 19.24 | 34.65 | 34.76 | 1.43 | -- | 9.72 | 2,414,664.00 | 77.82 | 33.25 | 91.17 | 38.12 | 80.19 | 74.66 | 54.54 | 39.63 | -- | -- | 0.0198 | 0.00 | 1,196.46 | 113.19 | 52,243.55 | -- | 75.67 | -- |
| Axonics Inc | 161.94m | -76.25m | 2.03bn | 416.00 | -- | 4.13 | -- | 12.51 | -1.83 | -1.83 | 3.90 | 10.59 | 0.3563 | 1.04 | 7.31 | 389,274.00 | -16.78 | -- | -18.10 | -- | 63.27 | -- | -47.09 | -- | 9.36 | -8.10 | 0.0002 | -- | 707.06 | -- | 31.30 | -- | -- | -- |
| Pacific Biosciences of California Inc | 121.63m | -36.96m | 2.08bn | 412.00 | -- | 2.47 | -- | 17.08 | -0.2459 | -0.2459 | 0.5835 | 3.81 | 0.1042 | 3.98 | 6.80 | 295,218.40 | -3.17 | -37.11 | -3.44 | -46.53 | 43.98 | 39.54 | -30.39 | -74.86 | 19.99 | -15.36 | 0.5159 | -- | -13.20 | -3.19 | 134.95 | -- | -19.16 | -- |
| Nevro Corp | 393.88m | -108.36m | 2.19bn | 843.00 | -- | 6.86 | -- | 5.56 | -3.12 | -3.12 | 11.35 | 9.15 | 0.5789 | 1.35 | 5.54 | 467,231.30 | -15.92 | -12.91 | -20.71 | -15.32 | 69.80 | 69.17 | -27.51 | -17.96 | 5.97 | -2.92 | 0.318 | -- | -7.23 | 39.07 | 19.89 | -- | 3.77 | -- |
| Haemonetics Corporation | 933.83m | 31.24m | 2.24bn | 2.71k | 72.37 | 3.20 | 18.26 | 2.40 | 0.6049 | 0.6049 | 18.26 | 13.68 | 0.5801 | 1.59 | 6.60 | 344,839.40 | 1.94 | 3.92 | 2.41 | 4.91 | 46.61 | 46.02 | 3.35 | 5.59 | 1.31 | 5.84 | 0.5278 | 0.00 | -11.94 | -0.859 | 3.85 | -- | -18.40 | -- |
| Glaukos Corp | 294.01m | -38.37m | 2.28bn | 653.00 | -- | 3.79 | -- | 7.74 | -0.8477 | -0.8477 | 6.31 | 12.83 | 0.2856 | 3.50 | 8.63 | 450,237.40 | -3.73 | -6.01 | -3.94 | -6.60 | 76.41 | 78.99 | -13.05 | -12.37 | 7.60 | -3.74 | 0.3697 | -- | -5.07 | 25.69 | -880.26 | -- | -15.27 | -- |
| Adapthealth Corp | 2.12bn | -42.36m | 2.36bn | 8.70k | -- | 1.19 | 16.58 | 1.12 | -1.60 | -1.60 | 18.07 | 15.06 | 0.6276 | 22.83 | 8.55 | 243,119.00 | -1.87 | -- | -2.13 | -- | 21.01 | -- | -2.98 | -- | 1.44 | 1.58 | 0.5278 | -- | 102.15 | -- | -657.38 | -- | -- | -- |
| Integer Holdings Corp | 1.18bn | 88.45m | 2.53bn | 7.50k | 28.81 | 1.90 | 14.96 | 2.15 | 2.66 | 2.66 | 35.43 | 40.35 | 0.4907 | 5.55 | 5.50 | 156,936.40 | 3.69 | 2.29 | 3.94 | 2.47 | 27.89 | 29.44 | 7.51 | 5.19 | 1.88 | 4.54 | 0.3213 | 0.00 | -14.68 | 6.05 | -15.30 | -- | 2.89 | -- |
| NuVasive, Inc. | 1.13bn | -25.66m | 2.59bn | 2.70k | -- | 3.14 | 21.40 | 2.29 | -0.4976 | -0.4976 | 21.85 | 15.95 | 0.4712 | 1.05 | 5.58 | 418,044.40 | -1.07 | 1.55 | -1.36 | 1.81 | 71.35 | 72.62 | -2.27 | 2.57 | 2.35 | 1.77 | 0.5176 | 0.00 | -10.06 | 5.31 | -156.95 | -- | 0.3312 | -- |
| Patterson Companies, Inc. | 6.38bn | 159.84m | 2.71bn | 7.80k | 17.01 | 2.68 | 11.31 | 0.4253 | 1.64 | 1.64 | 65.22 | 10.37 | 2.24 | 6.40 | 13.10 | 817,576.70 | 5.58 | -0.3475 | 9.28 | -0.492 | 20.11 | 21.73 | 2.49 | -0.1996 | 0.8125 | -- | 0.3844 | -- | 7.69 | 1.88 | 126.51 | -3.43 | -20.13 | 2.93 |
| AtriCure Inc. | 258.84m | 45.38m | 2.73bn | 750.00 | 64.14 | 5.58 | 49.46 | 10.54 | 0.9259 | 0.9259 | 5.82 | 10.63 | 0.392 | 1.80 | 8.78 | 345,114.70 | 6.87 | -8.44 | 7.43 | -9.35 | 74.67 | 72.67 | 17.53 | -17.00 | 2.91 | 30.38 | 0.1215 | -- | -10.52 | 9.74 | -36.83 | -- | -17.12 | -- |
| Merit Medical Systems, Inc. | 1.05bn | 43.22m | 2.97bn | 5.99k | 69.02 | 2.93 | 22.86 | 2.82 | 0.7628 | 0.7628 | 18.55 | 17.95 | 0.6363 | 2.81 | 7.20 | 176,033.20 | 2.61 | 1.36 | 2.97 | 1.52 | 44.36 | 43.60 | 4.10 | 2.17 | 1.20 | 13.45 | 0.2157 | 0.00 | -3.11 | 12.20 | -280.57 | -- | -1.41 | -- |
| Agape ATP Corp | 1.32m | -1.46m | 3.01bn | 35.00 | -- | 703.15 | -- | 2,277.13 | -0.0039 | -0.0039 | 0.0035 | 0.0114 | 0.2153 | 0.5409 | 9.56 | 37,787.14 | -23.82 | -- | -28.05 | -- | 79.79 | -- | -110.61 | -- | 4.27 | -49.54 | 0.00 | -- | -- | -- | -- | -- | -- | -- |
Data as of Jan 27 2022. Currency figures normalised to Adapthealth Corp's reporting currency: US Dollar USD
27.47%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Deerfield Management Company LPas of 30 Sep 2021 | 8.10m | 6.13% |
| The Vanguard Group, Inc.as of 30 Sep 2021 | 6.86m | 5.19% |
| BlackRock Fund Advisorsas of 30 Sep 2021 | 4.66m | 3.53% |
| Viking Global Investors LPas of 30 Sep 2021 | 4.07m | 3.08% |
| Wellington Management Co. LLPas of 30 Sep 2021 | 2.94m | 2.22% |
| Silvercrest Asset Management Group LLCas of 30 Sep 2021 | 2.52m | 1.90% |
| Rubric Capital Management LPas of 30 Sep 2021 | 2.30m | 1.74% |
| Swedbank Robur Fonder ABas of 30 Nov 2021 | 1.72m | 1.30% |
| Maverick Capital Ltd.as of 30 Sep 2021 | 1.60m | 1.21% |
| SSgA Funds Management, Inc.as of 30 Sep 2021 | 1.56m | 1.18% |
More ▼
Data from 30 Sep 2021 - 30 Nov 2021Source: FactSet Research Systems Inc.
